Pathway Therapeutics Limited
5 articles about Pathway Therapeutics Limited
-
Pathway Therapeutics Limited Announces Appointment of Mark Perry and Dr. Paul Goddard to its Board of Directors
8/16/2011
-
FDA Approves Trial of Pathway Therapeutics Limited Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio
5/25/2011
-
Pathway Therapeutics Limited Completes $4.5 Million Financing for Novel PI3K Inhibitor Portfolio
8/10/2010
-
Pathway Therapeutics Limited Release: New Zealand First To Benefit From New Trans-Tasman Funding Entity
12/3/2008
-
New Zealand Company, Pathway Therapeutics Limited Raises $9.6M Series A
6/18/2008